NAC in Preventing CIN in CRF Patients Who Need Enhanced CT Scan in ED
NCT00501475 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2010-07-27
Summary
The purpose of this study is to evaluate the effect of NAC or sodium bicarbonate in preventing the aggravation of renal function in chronic renal failure when enhanced computed tomography scan is checked in emergency room.
Conditions
- Chronic Renal Failure
Interventions
- DRUG
-
NAC Bicarbonate
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Principal Investigators
-
Kyuseok Kim, MD · Seoul National University Bundang Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-03-31
- Completion
- 2010-10-31
Countries
- South Korea
Study Locations
More Related Trials
-
NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial
NCT02483143 ·Status: COMPLETED ·Phase: PHASE4
-
Sodium Bicarbonate and N-Acetylcysteine for Nephroprotection in Acute Myocardial Infarction
NCT01218178 ·Status: COMPLETED
-
The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease
NCT00498342 ·Status: COMPLETED ·Phase: NA
-
A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate
NCT00579995 ·Status: TERMINATED ·Phase: NA
-
Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure
NCT00716001 ·Status: UNKNOWN ·Phase: PHASE4
-
Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material
NCT00558142 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
NCT01160627 ·Status: COMPLETED ·Phase: NA
-
Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)
NCT01232257 ·Status: COMPLETED ·Phase: PHASE3
-
Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects
NCT00888290 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Preventing Contrast Nephropathy With Sodium Bicarbonate in Patients With Pulmonary Edema,Heart Failure,Uncontrolled HTN
NCT00513825 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of N-Acetylcysteine on Residual Renal Function in Chronic Hemodialysis Patients
NCT00507052 ·Status: UNKNOWN ·Phase: NA
-
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
NCT02476526 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure
NCT00575419 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury
NCT01210456 ·Status: UNKNOWN ·Phase: PHASE3
-
Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine
NCT00353340 ·Status: COMPLETED ·Phase: NA
-
COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of contrasT
NCT00497328 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
NCT00808795 ·Status: COMPLETED ·Phase: PHASE3
-
N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography
NCT00830193 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
N-acetylcysteine Plus Deferoxamine for Patients With Hypotension
NCT00870883 ·Status: COMPLETED ·Phase: PHASE2
-
N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients
NCT00780962 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of N-acetylcysteine on Renal Functioning of Chronic Kidney Diseases(CKD) Patients After General Anesthesia
NCT01251029 ·Status: UNKNOWN ·Phase: PHASE1
-
Comparative Study of the Efficacy of Oral Versus Intravenous Hydration as a Preventive Measure of Contrast-induced Nephropathy (CIN) in Patients With Renal Insufficiency (RI) Grade III Under Study Conducting Computed Tomography (CT)
NCT02872155 ·Status: COMPLETED ·Phase: PHASE3
-
NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization
NCT00356954 ·Status: COMPLETED ·Phase: PHASE4
-
N-acetyl-cysteine (NAC) and Kidney Graft Function
NCT00998972 ·Status: COMPLETED ·Phase: PHASE3
-
Perioperative Use of NAC to Prevent AKI in Patients With Pre-existing Moderate Renal Insufficiency Following Cardiac Surgery
NCT05555511 ·Status: UNKNOWN ·Phase: NA